Clinical Trial Update: Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating adding atezolizumab to standard radiation therapy for patients with early-stage non-small cell lung cancer to determine p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 | Phase 3 | Status: ACTIVE_NOT_RECRUITING